A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in all cases where isolates demonstrated ceftolozane-tazobactam minimum inhibitory concentrations ≥8 μg/mL.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850333 | PMC |
| http://dx.doi.org/10.1093/cid/cix014 | DOI Listing |
Publication Analysis
Top Keywords
carbapenem-resistant pseudomonas
8
pseudomonas aeruginosa
8
multicenter evaluation
4
evaluation ceftolozane/tazobactam
4
ceftolozane/tazobactam serious
4
serious infections
4
infections caused
4
caused carbapenem-resistant
4
aeruginosa multicenter
4
multicenter retrospective
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!